APA (7th ed.) Citation

Hlapčić, I., Hulina-Tomašković, A., Somborac-Bačura, A., Rajković, M. G., Dugac, A. V., Popović-Grle, S., & Rumora, L. (2019). Extracellular adenosine triphosphate is associated with airflow limitation severity and symptoms burden in patients with chronic obstructive pulmonary disease. Scientific reports, 9(1), 15349-10. https://doi.org/10.1038/s41598-019-51855-w

Chicago Style (17th ed.) Citation

Hlapčić, Iva, Andrea Hulina-Tomašković, Anita Somborac-Bačura, Marija Grdić Rajković, Andrea Vukić Dugac, Sanja Popović-Grle, and Lada Rumora. "Extracellular Adenosine Triphosphate Is Associated with Airflow Limitation Severity and Symptoms Burden in Patients with Chronic Obstructive Pulmonary Disease." Scientific Reports 9, no. 1 (2019): 15349-10. https://doi.org/10.1038/s41598-019-51855-w.

MLA (9th ed.) Citation

Hlapčić, Iva, et al. "Extracellular Adenosine Triphosphate Is Associated with Airflow Limitation Severity and Symptoms Burden in Patients with Chronic Obstructive Pulmonary Disease." Scientific Reports, vol. 9, no. 1, 2019, pp. 15349-10, https://doi.org/10.1038/s41598-019-51855-w.